497 related articles for article (PubMed ID: 36810281)
21. N6-methyladenosine (m6A) modification in gynecological malignancies.
Zhang C; Liu N
J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
[TBL] [Abstract][Full Text] [Related]
22. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.
Tan F; Zhao M; Xiong F; Wang Y; Zhang S; Gong Z; Li X; He Y; Shi L; Wang F; Xiang B; Zhou M; Li X; Li Y; Li G; Zeng Z; Xiong W; Guo C
J Exp Clin Cancer Res; 2021 Apr; 40(1):146. PubMed ID: 33926508
[TBL] [Abstract][Full Text] [Related]
23. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
[TBL] [Abstract][Full Text] [Related]
24. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J; Huang T; Deng Z; Zou C
Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
[TBL] [Abstract][Full Text] [Related]
25. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Chen M; Wong CM
Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
[TBL] [Abstract][Full Text] [Related]
26. The role of m6A RNA methylation in cancer.
Sun T; Wu R; Ming L
Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
[TBL] [Abstract][Full Text] [Related]
27. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
28. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
29. The roles of RNA N
Teng C; Kong F; Mo J; Lin W; Jin C; Wang K; Wang Y
Heliyon; 2022 Nov; 8(11):e11430. PubMed ID: 36387447
[TBL] [Abstract][Full Text] [Related]
30. N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4.
van den Homberg DAL; van der Kwast RVCT; Quax PHA; Nossent AY
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162982
[TBL] [Abstract][Full Text] [Related]
31. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
32. M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications.
Bai X; Huang J; Jin Y; Chen J; Zhou S; Dong L; Han X; He X
Cell Death Discov; 2024 Feb; 10(1):83. PubMed ID: 38365891
[TBL] [Abstract][Full Text] [Related]
33. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
[TBL] [Abstract][Full Text] [Related]
34. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
Front Surg; 2022; 9():819335. PubMed ID: 35155557
[TBL] [Abstract][Full Text] [Related]
35. The role of m6A methylation in therapy resistance in cancer.
Zhuang H; Yu B; Tao D; Xu X; Xu Y; Wang J; Jiao Y; Wang L
Mol Cancer; 2023 Jun; 22(1):91. PubMed ID: 37264402
[TBL] [Abstract][Full Text] [Related]
36. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
37. Emerging Roles of m
Huang W; Kong F; Li R; Chen X; Wang K
Front Oncol; 2022; 12():827956. PubMed ID: 35155260
[TBL] [Abstract][Full Text] [Related]
38. N
Dong S; Wu Y; Liu Y; Weng H; Huang H
Cancer Commun (Lond); 2021 Jul; 41(7):538-559. PubMed ID: 33955720
[TBL] [Abstract][Full Text] [Related]
39. New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.
Jin Y; Fan Z
Cell Prolif; 2024 Apr; 57(4):e13578. PubMed ID: 37961996
[TBL] [Abstract][Full Text] [Related]
40. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Maity A; Das B
FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
